Back to Schonfeld Strategic Advisors LLC Schonfeld Strategic Advisors LLC

LGND

6 quarters

Position history for Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC's holdings in Ligand Pharmaceuticals Incorporated

No. Schonfeld Strategic Advisors exited its LGND (Ligand Pharmaceuticals) position in Q2 2024. Its Q1 2024 13F listed 9,121 shares worth $666,745. Schonfeld Strategic Advisors first reported LGND in Q2 2019 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$231,000

Total Shares Change

-2,022

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%$84.26
0
2024-Q1
New
9,121
-
$666,7450.0%$73.10
34
2022-Q4
Exited
0
-100.0%
$00.0%$66.80
0
2022-Q3
New
3,136
-
$270,0000.0%$53.72
32
2019-Q3
Exited
0
-100.0%
$00.0%$62.10
0
2019-Q2
New
2,022
-
$231,0000.0%$71.21
32

Other major holders of LGND: BlackRock, Inc., Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used